The Retatrutide Crackdown: Eli Lilly, Research Peptides, and the Legal Risks Nobody Wants to Discuss
The peptide industry is entering a period where the consequences of selling, prescribing, and distributing unapproved compounds could become much more serious. With Eli Lilly pursuing legal action against companies selling retatrutide, the...
